Home
>
US Stocks
>
Arvinas Inc
Arvinas Inc
ARVN

Arvinas Inc (ARVN)

$84.91.74%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
$87.28
Today Low/High
$83.36 / $87.28
52 Week Low/High
$19.68 / $108.47
Market Cap
$4.28B

Company Details

Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. In addition to its robust preclinical pipeline of PROTAC® protein degraders against validated and "undruggable" targets, the company has two clinical-stage programs: ARV-110 for the treatment of men with metastatic castrate-resistant prostate cancer; and ARV-471 for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer.
Organisation
Arvinas Inc
Employees
179
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Arvinas Inc (ARVN) share price today?

Can Indians buy Arvinas Inc (ARVN) shares?

How can I buy Arvinas Inc (ARVN) shares from India?

Can Fractional shares of Arvinas Inc (ARVN) be purchased?

What are the documents required to start investing in Arvinas Inc (ARVN) stocks?

We are a SEBI registered investement advisor